Cerus (CERS) Net Income towards Common Stockholders (2010 - 2026)
Cerus (CERS) posted Net Income towards Common Stockholders of -$3.0 million for Q2 2026, down 80.95% sequentially from -$1.6 million in Q1 2026, and up 47.82% YoY from -$2.0 million in Q2 2025.
Cerus (CERS) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Cerus has reported Net Income towards Common Stockholders for 17 years, with the latest figure at -$3.0 million in Q2 2026.
- Quarterly Net Income towards Common Stockholders rose 47.82% year-over-year to -$3.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$5.7 million (up 61.83% YoY) and the FY2025 annual result came in at -$14.5 million, up 14.5% from the prior year.
- Net Income towards Common Stockholders fell to -$3.0 million in Q2 2026 per CERS's latest filing, from -$1.6 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $5.8 million in Q4 2023 and troughed at -$15.6 million in Q1 2023.
- A 5-year average of -$5.6 million and a median of -$5.7 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders sank 370.54% in 2022, then soared 216.18% in 2023.
- Over 5 years, Net Income towards Common Stockholders stood at -$5.0 million in 2022, then jumped by 216.18% to $5.8 million in 2023, then slumped by 75.24% to $1.4 million in 2024, then sank by 172.71% to -$1.0 million in 2025, then slumped by 184.81% to -$3.0 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$3.0 million, -$1.6 million, and -$1.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | -2.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.98 Mn |
| Mar 31, 2026 | -1.65 Mn |
| Dec 31, 2025 | -2.18 Mn |
| Sep 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -5.72 Mn |
| Mar 31, 2025 | -7.72 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | -2.93 Mn |
| Jun 30, 2024 | -5.78 Mn |
| Mar 31, 2024 | -9.69 Mn |
| Dec 31, 2023 | -1.39 Mn |
| Sep 30, 2023 | -7.29 Mn |
| Jun 30, 2023 | -13.33 Mn |
| Mar 31, 2023 | -15.64 Mn |
| Dec 31, 2022 | -14.38 Mn |
| Sep 30, 2022 | -8.52 Mn |
| Jun 30, 2022 | -8.40 Mn |
| Mar 31, 2022 | -12.28 Mn |
| Dec 31, 2021 | 2.55 Mn |
| Sep 30, 2021 | -12.44 Mn |